BIOMAT Database Logo BIOMAT Database Logo

Topical dinitrochlorobenzene (DNCB) for alopecia areata: Revisited. 2008

K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene
D006241 Haptens Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. Hapten,Contact-Sensitizing Agents,Agents, Contact-Sensitizing,Contact Sensitizing Agents
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000506 Alopecia Areata Loss of scalp and body hair involving microscopically inflammatory patchy areas. Alopecia Circumscripta
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
[Topical treatment of alopecia areata with dinitrochlorobenzol (DNCB)].
September 1979, Zeitschrift fur Hautkrankheiten,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
Dinitrochlorobenzene therapy for alopecia areata.
November 1978, Archives of dermatology,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
Dinitrochlorobenzene in alopecia areata.
December 1978, Lancet (London, England),
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
Alopecia areata treated with DNCB.
September 1979, Clinical and experimental dermatology,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
[DNCB therapy of alopecia areata].
May 1979, Zeitschrift fur Hautkrankheiten,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
[Dinitrochlorobenzene treatment of alopecia areata].
September 1980, Nederlands tijdschrift voor geneeskunde,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
Dinitrochlorobenzene treatment of alopecia areata.
August 1982, Archives of dermatology,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
Dinitrochlorobenzene therapy in alopecia areata.
January 1991, Journal of the Indian Medical Association,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
[Pointer for DNCB therapy in alopecia areata].
October 1979, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
K H Mohan, and C Balachandran, and S D Shenoi, and Raghavendra Rao, and H Sripathi, and Smitha Prabhu
[DNCB therapy for alopecia areata (author's transl)].
January 1980, Dermatologica,
Copied contents to your clipboard!